journal article·2002-08

Effect of tricaprin on the physical characteristics and in vitro release of etoposide from PLGA microspheres

Matthew J Schaefer, Jagdish Singh

Biomaterials· Volume 23· Issue 16
Publisher page

Abstract

The purpose of this article is to examine the effects of tricaprin on the physical characteristics and in vitro release of etoposide from poly (lactic-co-glycolic acid) microspheres. The microspheres were synthesized through the use of a single-emulsion solvent-extraction procedure. Samples from each batch of microspheres were then analyzed for size distribution, drug loading efficiency, surface characteristics, in vitro release, and in vitro degradation of microspheres. Microsphere batches were synthesized using three different etoposide concentrations (15%, 10%, and 5% w/w) with tricaprin concentrations of 25% and 50%. The incorporation of 50% tricaprin significantly increased (p<0.05) the size of the microspheres for all three etoposide concentrations in comparison to microspheres prepared without tricaprin (control). The percentage of tricaprin used did not significantly affect the drug loading efficiency of the microspheres. The addition of tricaprin was shown to significantly increase (p<0.05) the in vitro release of etoposide from the microspheres prepared with all three concentrations of etoposide and the two different tricaprin percentages. Examination of the surface characteristics of the tricaprin loaded microspheres showed a dimpled surface with what appeared to be pockets of tricaprin dispersed throughout. In the in vitro degradation study, the tricaprin microspheres grew very porous as the degradation time increased, but they still retained a recognizable structure even after 30 days of degradation.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Advanced Drug Delivery Systems · Pneumocystis jirovecii pneumonia detection and treatment · Plant-derived Lignans Synthesis and Bioactivity

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (27)

Show source-provided references
1. Albumin microspheres for intra-arterial tumor targeting. I. Pharmaceutical aspects10.1016/0378-5173(85)90160-7 ↗
2. Chasin M, Langer R, editors. Biodegradable polymers as drug delivery systems. New York: Marcel Dekker Inc., 1990. p. 1–41.
3. Etoposide microspheres for targeting to the lung
4. Controlled release captopril microcapsules10.3109/02652049009028424 ↗
5. Preparation, characterization and in-vitro release kinetics of salbutamol sulfate loaded albumin microspheres10.3109/03639049409038377 ↗
6. Preparation, characterization and in-vitro release kinetics of aminophylline loaded albumin microspheres
7. Aminophylline targeting to lung10.3109/02652049109021239 ↗
8. Clearance of 141 Ce-labelled microspheres in specific organs following intravenous and intra-arterial administration in beagle dogs10.1002/jps.2600690703 ↗
9. Targeting of colloidal particles to the bone marrow10.1016/0024-3205(87)90120-2 ↗
10. Guiot P, Couvreur M, editors. Polymeric nanoparticles and microspheres. Boca Raton, FL: CRC Press, 1986. p. 175.
11. Recent advances in the use of microspheres for targeted therapy
12. David SS, Illum L, McVie JG, Tomlinson E, editors. Microspheres and drug therapy. New York: Elsevier, 1984. p. 205–16.
14. Etoposide
15. In vitro pharmacodynamic evaluation of VP-16213 and implications for chemotherapy
16. Controlled release of bioactive agents from lactide/glycolide polymers
17. Controlled delivery systems for proteins based on poly (lactic/glycolic acid) microspheres10.1023/A:1015841715384 ↗
18. Kostanski JW, DeLuca PP. A novel in vitro release technique for peptide-containing biodegradable microspheres. AAPS PharmSciTech 2000;1(1). Available at http://www.pharmscitech.com [article 4].10.1007/BF02830519 ↗
19. Ravivarapu HB, Moyer KL, Dunn RL. Sustained activity and release of leuprolid eacetate from an in situ forming polymeric implant. AAPS PharmSciTech 2000;1(1). Available at http://www.pharmscitech.com [article 1].10.1208/pt010101 ↗
20. Kostanaski JW, Dani BA, Reynolds G-A, Bowers CY, DeLuca PP. Evaluation of orntide microspheres in rat animal model and correlation to in vitro release profiles. AAPS PharmSciTech 2000;1(4). http://www.pharmscitech.com [article 27].10.1208/pt010427 ↗
21. Gebrekidan S, Woo BH, DeLuca PP. Formulation and in vitro transfection efficiency of poly (d, l- lactide-co-glycolide) microspheres containing plasmid DNA for gene delivery. AAPS PharmSciTech 2000;1(4). http://www.pharmscitech.com [article 28].10.1208/pt010428 ↗
22. Controlled delivery by biodegradable poly(ester) devices10.3109/03639049809082719 ↗
23. Pharmacokinetic study of taxol- loaded poly(lactic-co-glycolic acid) microspheres containing isopropyl myristate after targeted delivery to the lung in mice10.1248/bpb.19.1596 ↗
24. Preparation and characterization of poly(lactic-co-glycolic acid) microspheres for targeted delivery of a novel anticancer agent10.1248/cpb.44.1935 ↗
25. Modification of the release rate of aclarabicin from polylactic acid microspheres10.1248/cpb.33.1734 ↗
26. Influence of additives on the release profile of nifedipine from poly(DL-lactide-co-glycolide) microspheres10.3109/02652049809008239 ↗
27. Stability-indicating high performance liquid chromatography of etoposide at various pH conditions using a reversed-phase octyl column10.1016/S0021-9673(01)94059-2 ↗